Garrison LP Jr, Neumann P J, Radensky P,et al. A flexible approach to evidentiary standards for comparative effectiveness research [J]. Health Aff (Millwood), 2010,29(10):1812.
[2]
Sox H C. Comparative effectiveness research: a progress report[J]. Ann Intern Med, 2010,153(7):469.
[3]
Dreyer N A, Tunis S R, Berger M, et al. Why observational studies should be among the tools used in comparative effectiveness research[J]. Health Aff (Millwood), 2010,29(10):1818.
[4]
Patient Protection Affordable Care Act-H. R. 3590. 2012-8-10.http://www.opencongress.org/bill/111-h3590/show.
[5]
Institute of Medicine. Initial national priorities for comparative effectiveness research[M]. Washington, DC: The National Academies Press, 2009.
[6]
Federal Coordinating Council for Comparative Effectiveness Research. Report to the president and congress. Washington, DC: Department of Health and Human Services, 2009.
[7]
Lind J. A treatise of the scurvy in three parts[M]. London: A Millar, 1753.
[8]
Mamdani M, McNeely D, Evans G, et al. Impact of a uoroquinolone restriction policy in an elderly population [J]. Am J Med,2007,120:893.
[9]
Eden J, B Wheatley, B J McNeil, et al. Knowing what works in health care: a roadmap for the nation[M]. Washington, DC: National Academies Press,2008.
[10]
VanLare J M, Conway P H, Sox H C N. Five next steps for a new national program for comparative-effectiveness research [J]. Engl J Med,2010, 362(11):970.
[11]
Good ReseArch for Comparative Effectiveness.2013-1-7. http://www.graceprinciples.org/.
[12]
Berger M L, Mamdani M, Atkins D, et al.Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report-Part I [J].Value Health,2009,12(8):1044.
[13]
Cox E, Martin B C, Van Staa T,et al. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the international society for pharmacoeconomics and outcomes research good research practices for retrospective database analysis task force repor-Part II[J].Value Healt
[14]
Conway P H, Clancy C. Charting a path from comparative effectiveness funding to improved patient-centered health care[J]. J Amer Med Assoc, 2010,303(10):985.
Institute of Medicine. Learning what works best: The nation\'s need for evidence on comparative effectiveness in health care 2007. 2013-1-7. http://www.iom.edu/ebm-effectiveness.
[18]
Congressional Budget Office. Research on the comparative effectiveness of medical treatments. 2012-7-8. http://www.cbo.gov/publication/41655.
[19]
C Schoen, S Guterman, A Shih J,et al. Bending the curve: options for achieving savings and improving value in U.S. health spending.. 2012-7-8. http://www.commonwealthfund.org/publ...doc_id=620087 on 12/18/2007.
[20]
Concato J, Peduzzi P, Huang GD, et al. Comparative effectiveness research: what kind of studies do we need? [J]. J Investig Med, 2010, 58(6):764.
[21]
Michael Hochman, Danny McCormick. Characteristics of published comparative effectiveness studies of medications[J]. J Amer Med Assoc, 2010,303(10):951.
[22]
Hove E, Pittman P. A first look at the volume and cost of comparative effectiveness research in the united atates[M]. Washington, DC: Academy Health, 2009.
[23]
Erin Holve, Patricia Pittman.Cost and volume of current comparative effectiveness research..http://www.nhpf.org/library/handouts/Holve.slides_10-03-08.pdf.
[24]
William Wang, Nancy Santanello. Study designs in comparative effectiveness research.. http://coresummit.org/doc/William_Wang.pdf.
[25]
Federal Coordinating Council for Comparative Effectiveness Research. Report to the president and the congress.. http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf.
[26]
Rockville M D. Methods guide for effectiveness and comparative effectiveness reviews.. http://www.effectivehealthcare.ahrq.gov/ehc/products/60/318/Meth桯??ぇふ?????????ぢ????扴物?孮??嵲??潴桟渲猰漱渲‰?′????牦漮眼湢?圾?′?慝爠瑍楥湤??????敡瑲?愮氮?‰?漲漭搸?爷攮獨整慴牰挺栯?灪牯慵捲瑮楡捬敳献?晷潷爮?捯潭洯灬慷牷愭瑭楥癤敩?敡晬晣敡捲瑥椯癴敯湣支猲猰?爰支猰收愰爰挱栮??慲渾慛氲礲瑝椠捍?浤敩瑣桡潬搠獃?瑲潥?椮洲瀰爱漲瘭攸?挷愮畨獴慴汰?椯港晪敯牵敲湮捡敬?昮牬潷海?湣潯湭爯慬湷摷漭浭楥穤敩摣?獬瑣畡摲楥支獴?潣是′琰爰攷愯琱洰攰渰琲?攼晢晲放捛琲猳?甠獓楥湡杮?獔敵据潩湳搠慍爠祄?搠慃瑯慭?獡潲畡牴捩敶獥??瑦桦敥??卩偶佥剮?杳潳漠摲?牳敥獡敲慣牨挠桭?灴牨慯捤瑳椠捡敮獤?晲潥牳?牡敲瑣牨漠獩灮敦捲瑡楳癴敲?摣慴瑵慲扥愮献攠′愰渱愲氭礷猭椸献?瑨慴獴歰?是漯牷捷敷?牥敨灣潣牡琮?偯慭爯瑰????孮?嵡?噩慯汮畳支??敭慰汥瑦桦???どぶ??????????????戮爼?孲??崲??匠偖佯剮?杅潬潭搠?瀬爠慁捬瑴業捡敮猠?映潇爬?潐畯瑣捯潣浫攠獓?牊攬猠敥慴爠捡桬?椠湓摴敲硥???と????????桥琠瑲灥???睴睩睮?椠獯灦漠牯?潳牥杲?睡潴物歯灮慡灬攠牳?灵牤慩捥瑳椠捩敮猠彥楰湩摤敥硭?慯獬灯?y (STROBE) statement: guidelines for reporting observational studies [J]. Bri Med J, 2007,335:806.
[27]
Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs[J]. Epidemiology, 1996, 7:231.
